Abstract: Fused tetracyclic benzodiazepines of the formula (I): ##STR1## where R.sup.1 is a cyclic amine such as 1-piperazine and R.sup.2 is H or a substituent as defined herein are useful as antiovulatory and contragestational agents. Also, methods for their synthesis, intermediates used in such synthesis, methods for use as medicaments and pharmaceutical compositions are described.
Abstract: Compounds of the present invention are of the formula (III): ##STR1## wherein R.sup.2 is a substituent as disclosed, R is alkyl and Y is NO.sub.2 or NH.sub.2. The invention compounds are useful as intermediates for tetracyclic benzodiazepines which may be used in treating hypertension.
Abstract: Novel pyrrole-2-acetylamino compounds of the formula: ##STR1## and salts thereof, wherein R" is H, alkyl, (CH.sub.2).sub.n CO.sub.2 H, CH.sub.2 CH.sub.2 SCH.sub.3, (CH.sub.2).sub.4 NH.sub.2 or (CH.sub.2).sub.2 CONH.sub.2 ; and n is 1 or 2, which have the same analgesic and antiinflammatory utility as zomepirac, but with reduced liability toward gastrointestinal irritation, and esters of the compounds of the above formula which are useful as intermediates to make said compounds.
Abstract: Various indole and benzothiophene compounds having a pendant pyrrolidinylidene amino or piperidinylideneamino group are useful in the prevention of ventricular fibrillation, e.g., in humans. The invention comprises methods for the treatment of ventricular dysrhythymia or the prevention of ventricular fibrillation.
Abstract: Sulfamates of the following formula (I): ##STR1## wherein X is O or CH.sub.2 and R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are as herein defined have been found to exhibit anticonvulsant activity and are thus useful in the treatment of conditions such as epilepsy. Further, pharmaceutical compositions containing a compound of formula (I) as well as methods for their use and intermediates form part of the present invention.
Abstract: Octahydroindolizidines of the formula (I): ##STR1## where A is a 3-7 carbon or hetero-containing ring, R.sup.1 is a substituent and x is 0-3. Also, pharmaceutical composition for treating pain and methods for synthesis and use as well as novel intermediates in the synthesis.
Abstract: Compounds of the class of loweralkyl N-[amino(arylaminocarbonyl)iminomethyl]-N-methylglycinate acid addition salts are useful as antianxiety agents.
Abstract: Hexahydroindolizines of the following formulae (I) and (II): ##STR1## are novel and have been found to possess antisecretory and antidepressant properties. Methods of preparation, intermediates thereto and use are also disclosed.
Abstract: Aryl fatty acid compounds of the formula (I) ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, X, and Y are as defined herein are novel and useful in the treatment of allergic and inflammatory disorders.
Abstract: Fused tetracyclic benzodiazepines of the formula (I): ##STR1## where R.sup.1 is an acyclic amine or cyclic amine such as 1-piperidine, 4-morpholine or 1-piperazine and R.sup.2 is H or a substituent as defined herein as useful as antiallergins. Also, methods for their synthesis, intermediate used in such synthesis, methods for use as medicaments and pharmaceutical compositions.
Abstract: N-aryl-N'-(2-thiazolidinylidene)urea compounds of Formula II ##STR1## wherein: R is CH.sub.3, C.sub.2 H.sub.5, or H;R.sub.1 is CH.sub.3, C.sub.2 H.sub.5, Cl, Br, F, CF.sub.3, OCH.sub.3 or H, provided that R.sub.1 is not H where R is H;R.sub.2 is CH.sub.3 or H, provided that R.sub.2 is not H when R is H;R.sub.3 is H or F or CH.sub.3 ;R.sub.4 is H or CH.sub.3 ;R.sub.5 is CH.sub.3, C.sub.2 H.sub.5, Cl, Br, F, CF.sub.3, OCH.sub.3, have anticonvulsant activity and are useful in the treatment of epilepsy.
Abstract: Compounds of the present invention are of the formula (I): ##STR1## wherein X is oxygen or two hydrogens, R.sup.1 is a variety of substituents or hydrogen and R.sup.2 is hydrogen, alkoxy, alkyl, CF.sub.3, halogen, NO.sub.2, OH or dialkylamino. The compounds are useful as blood pressure lowering agents and may be used in the treatment of hypertension. Also, part of the invention are pharmaceutical compositions and uses and intermediates for compounds of formula (I).
Abstract: Novel compounds, which are aryl-pyrrolyl-imine derivatives of the Formula I ##STR1## and acid addition salts thereof are disclosed; which compounds may be prepared by the acid catalyzed condensation of an imidoyl chloride with a lower alkyl pyrrole-2-acetate; and which compounds are useful as intermediates to form by hydrolysis, the known useful ketone analogs which have anti-inflammatory and analgesic activity; and certain of which compounds have antisecretory, anti-irritable bowel, antidiarrheal and general behavior effect on the CNS properties.
Abstract: Compounds of the following formula (I): ##STR1## wherein Alk is a straight or branched chain alkylene of about 1 to 12 carbons and R.sup.1 is a heterocyclic ring system, have been found to possess potent antisecretory activity and are thus useful in the treatment of hyperacidity.
Abstract: Novel 2-amino-4,5-dihydro-1H-imidazole-1-carboxanilides, which are made by reacting 2-amino-4,5-dihydroimidazole with an aryl isocyanate, are made stable to rearrangement when converted to acid addition salt form, and are useful either as antihypertensive agents and/or antisecretary agents, as well as being intermediates to prepare known pharmacologically active N-aryl-N'-(4,5-dihydro-1H-imidazol-2-yl)ureas.
Abstract: An improved process for producing the hypoglycemic compound, methyl 2-tetradecylglycidate, by reacting methyl .alpha.-chloropalmitate with lithium methoxide in the presence of formaldehyde in a dipolar aprotic solvent such as DMF or DMSO.
Abstract: An improved process for preparing fenoctimine, which is 4-(diphenylmethyl)-1-[(octylimino)methyl]piperidine by: (1) reacting dimethylformamide with dimethyl sulfate to form a complex; (2) reacting the resultant dimethylformamide/dimethyl sulfate complex with n-octylamine and optionally with dimethylamine; (3) thereafter treating the reaction with aqueous base to form N,N-dimethyl-N'-octyl-formamidine; and (4) reacting said formamidine, without need for further purification, with 4-(diphenylmethyl) piperidine to obtain 4-(diphenylmethyl)-1-[(octylimino)-methyl]piperidine.
Abstract: Hydroxythioether fatty acid derivatives of formula (I) ##STR1## wherein n is 2-5, m is 8-12, R.sup.1 is OH, O-loweralkyl, NH.sub.2, NH-loweralkyl or NH-carboxyalkyl; R.sup.2 is OH or O-loweralkyl; X is H or NH.sub.2 or ##STR2## and salts thereof are useful in preventing or alleviating asthma or other allergic diseases.
Abstract: N-(substituted phenyl)-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)ureas and pharmaceutically-acceptable salts thereof are disclosed to be useful in relieving the symptoms associated with irritable bowel syndrome, and as anti-diarrheal agents.
Abstract: Hydroxythioether fatty acid derivatives of formula (I) ##STR1## wherein n is 2-5, m is 8-12, R.sup.1 is OH, O-loweralkyl, NH.sub.2, NH-loweralkyl or NH-carboxyalkyl, R.sup.2 is OH or O-lower-alkyl, X is H or NH.sub.2 or ##STR2## and salts thereof are useful in preventing or alleviating asthma or other allergic diseases.